Black Friday sale
PTCB Quiz Prep

USP 797 Sterile Compounding: Study Guide for Pharmacy Technicians

Updated

USP 797 is the United States Pharmacopeia's General Chapter <797>, the standard for compounding sterile preparations (CSPs) such as injections and IV infusions. The revised chapter became official on November 1, 2023. It sorts CSPs into Category 1, 2 and 3, and the category decides where a CSP is made and how long its beyond-use date (BUD) can be.

The chapter sets minimum standards for compounding personnel and their training, facilities, environmental monitoring, and the storage and testing of finished preparations. This guide covers categories and BUDs, ISO classes and hoods, hand hygiene and garbing, competency testing and immediate-use CSPs. It ends with the nonsterile chapter, USP 795, and a short note on how USP 800 fits in.

Where USP 797 sits on the PTCE

The PTCE content outline effective January 6, 2026 does not list compounding as a knowledge area. The material connects to knowledge area 3.6, infection prevention procedures and cleaning standards (handwashing, personal protective equipment and cleaning equipment), in the Patient Safety & Quality Assurance domain, which is 23.75% of the exam. The BUD side connects to knowledge area 1.7, drug stability, which names reconstitutables and injectables, in the Medications domain (35%). Knowledge area 4.2 lists injectable syringes, filters and dilution solutions among the supplies for drug administration.

PTCB offers a separate credential for sterile compounding, the Certified Compounded Sterile Preparation Technician (CSPT). Applicants must be active PTCB CPhTs, and PTCB republished the CSPT exam on November 1, 2023 to reflect the revised USP 797. Our guide to the CSPT exam covers eligibility and content.

What USP 797 covers and who has to follow it

USP defines sterile compounding as combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile medication. Medications that must be sterile include those given by injection, IV infusion, intraocular injection (into the eye) and intrathecal injection (into the spine).

The chapter applies to all persons who prepare CSPs and all places where CSPs are prepared for human and animal patients. That includes pharmacists, technicians, nurses and physicians. Anyone who enters a sterile compounding area must meet its hygiene and garbing rules, whether or not they are compounding. Repackaging a sterile product from its original container into another container is also covered.

Three things fall outside USP 797:

  • Preparation per approved labeling. Mixing or reconstituting a single dose for one patient exactly as the approved labeling directs is not compounding, as long as the labeling gives the diluent, the resulting strength, the container closure system and the storage time.
  • Administration. Withdrawing a dose from a container or spiking an IV bag with no further manipulation is administration. Mixing that dose with another product makes it compounding.
  • Radiopharmaceuticals and manufacturing.Compounded radiopharmaceuticals fall under USP <825>. Drug manufacturers follow FDA's current good manufacturing practices (CGMP) instead.

In USP chapters, "must" generally marks a requirement, and "should" or "may" marks a recommendation.

When the revised chapter became official

USP published the revised USP 797 on November 1, 2022, and it became official on November 1, 2023. USP's Compounding Expert Committee voted to extend the official date to November 1, 2023 to allow more flexibility for adoption. The revision replaced the old low-risk, medium-risk and high-risk levels with Category 1 and Category 2, and Category 3 was added in the 2021 proposed revision.

Who enforces USP 797

USP writes the standard but does not enforce it. USP says that ensuring compliance is the responsibility of the applicable regulatory jurisdiction and that USP has no role in enforcement. Regulators such as state boards of pharmacy may also set a different official date.

  • State boards of pharmacy have primary responsibility for the day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities. Some states write USP into law. Washington, for example, requires compounded products to meet, at a minimum, the standards of the official United States Pharmacopeia for nonsterile and sterile preparations.
  • FDA and section 503A.FDA also conducts surveillance and for-cause inspections of state-licensed pharmacies. Section 503A of the FD&C Act sets conditions for drugs compounded for an identified individual patient based on a valid prescription order. One condition is that ingredients other than bulk drug substances comply with an applicable USP or National Formulary monograph, if one exists, and the USP chapter on pharmacy compounding. Federal law on insanitary conditions applies wherever compounding happens, and compounded drugs are not FDA approved.
  • FDA and section 503B. Outsourcing facilities registered under section 503B are primarily overseen by FDA, inspected on a risk-based schedule, and subject to CGMP requirements. Drugs compounded in a state-licensed pharmacy under the conditions of section 503A are not subject to CGMP.

Category 1, 2 and 3 CSPs

USP distinguishes Category 1 and Category 2 CSPs primarily by the conditions under which they are made and the time within which they are used. Category 3 describes CSPs made in a facility that meets additional quality assurance requirements.

CategoryWhere it is compoundedBUD limit
Category 1ISO Class 5 PEC in an unclassified segregated compounding area (SCA) or in a cleanroom suite12 hours or less at controlled room temperature, 24 hours or less refrigerated
Category 2Cleanroom suite: ISO Class 7 or better buffer room, ISO Class 8 or better anteroomLonger than Category 1, set by compounding method, sterility testing, starting ingredients and storage (table below)
Category 3Cleanroom suite plus extra quality requirements, including sterility testing and sterile garbLonger than Category 2, up to a maximum of 180 days

Category 3 CSPs undergo sterility testing, supplemented by endotoxin testing when applicable. They also carry more requirements than Category 2 for personnel qualification, sterile garb, sporicidal disinfectants, environmental monitoring frequency and stability data.

USP 797 beyond-use dates (BUD) by category

A beyond-use date is the date, or date and time, after which a compounded preparation must not be used. It is counted from the date and time the preparation is compounded. These are the USP 797 limits:

CategoryHow it is madeRoom temperatureRefrigeratorFreezer
Category 1Any method12 hours or less24 hours or lessNot listed
Category 2Aseptically processed, no sterility testing, one or more nonsterile starting components1 day4 days45 days
Category 2Aseptically processed, no sterility testing, only sterile starting components4 days10 days45 days
Category 2Aseptically processed, sterility tested and passed30 days45 days60 days
Category 2Terminally sterilized, no sterility testing14 days28 days45 days
Category 2Terminally sterilized, sterility tested and passed45 days60 days90 days
Category 3Aseptically processed, sterility tested, passing all Category 3 tests60 days90 days120 days
Category 3Terminally sterilized, sterility tested, passing all Category 3 tests90 days120 days180 days

Room temperature means controlled room temperature. The Category 1 limits list only room temperature and refrigerator storage.

Three rules sit on top of the table:

  • The limits are maximums.A shorter BUD must be assigned when the CSP's stability or sterility is shorter than the limit for its category.
  • BUDs are not additive. A CSP given a room temperature BUD cannot later be refrigerated or frozen to extend that BUD.
  • Administration must start before the BUD. An infusion that began before the BUD lapsed is not cut off when the BUD passes.

Time limits for opened components

Components used to make CSPs have their own time limits once opened. USP notes that a BUD is not the same as this in-use time.

  • Single-dose vial: if entered or punctured only in ISO Class 5 or cleaner air, it may be used for up to 12 hours after first puncture, as long as its labeled storage conditions are kept.
  • Single-dose ampule: used immediately once opened and not stored for any time.
  • Multiple-dose container:not used for more than 28 days after it is first entered or punctured, unless the manufacturer's labeling says otherwise.

A BUD is different from the manufacturer's expiration date on a stock bottle. Our drug storage and expiration practice questions drill that difference along with storage temperatures.

Immediate-use CSPs

A CSP made for direct and immediate administration is not subject to the Category 1, 2 or 3 requirements when all of these conditions are met:

  1. Aseptic technique is followed, and written SOPs are in place.
  2. Staff are trained and have shown competency in aseptic processes for their tasks.
  3. The preparation follows evidence-based information on the physical and chemical compatibility of the drugs.
  4. No more than 3 different sterile products are used. Several containers of the same product count as one product.
  5. Any unused part of a single-dose container is discarded after preparation, and a single-dose container is never used for more than one patient.
  6. Administration begins within 4 hours of the start of preparation. If it has not begun by then, the CSP is discarded.
  7. Unless the person who prepared it administers it or watches it being administered, the CSP is labeled with the names and amounts of all active ingredients, the preparer's name or initials, and the 4-hour period within which administration must begin.

The older chapter used a 1-hour window. USP's FAQ says a facility may keep the 1-hour limit, but 4 hours is acceptable under the revised chapter.

ISO classes: ISO 5, ISO 7 and ISO 8

A sterile compounding facility must be designed so that air quality improves as you move through each area toward the PEC. Lower ISO class numbers mean cleaner air: an ISO Class 5 PEC sits in an ISO Class 7 buffer room, which is entered through an ISO Class 8 anteroom. The anteroom and buffer room together make up the cleanroom suite.

AreaMinimum air qualityWhat happens there
Primary engineering control (PEC)ISO Class 5 or betterWhere the CSP is compounded: a laminar airflow workbench, biological safety cabinet, CAI, CACI or similar device.
Buffer roomISO Class 7 or betterRoom with fixed walls and doors that holds the PEC. It can only be entered through the anteroom or another buffer room.
AnteroomISO Class 8 or better (ISO Class 7 if it opens onto a negative-pressure buffer room)Hand hygiene, garbing, staging of components, order entry and labeling. A line of demarcation splits its dirty and clean sides.
Segregated compounding area (SCA)UnclassifiedA space with a visible perimeter that contains a PEC. Category 1 CSPs only.

You enter the anteroom on its dirty side. The clean side is the part closest to the buffer room. Other numbers worth knowing:

  • ISO Class 7 rooms need at least 30 total HEPA-filtered air changes per hour (ACPH).
  • ISO Class 8 rooms need at least 20 total HEPA-filtered ACPH.
  • A nonhazardous suite keeps a positive pressure of at least 0.020-inch water column from buffer room to anteroom and from anteroom to the unclassified area.
  • Classified areas, including the PEC, are certified initially and recertified at least every 6 months.

The segregated compounding area (SCA)

An SCA is a designated space, area or room that does not have to be classified and is defined by a visible perimeter. It must contain a PEC and is suitable for Category 1 CSPs only. It does not have to be an enclosed room with walls and doors. It must be away from unsealed windows, doors to the outdoors and traffic flow, and it cannot be placed where restrooms, warehouses or food preparation areas could affect the air in the PEC. No sink may be within 1 meter of the PEC.

Laminar airflow workbenches, BSCs and other PECs

A primary engineering control (PEC) is a device or zone that provides ISO Class 5 air for sterile compounding. USP's own FAQs also call it the hood. The PEC supplies unidirectional HEPA-filtered air: air moving in a single direction, in a uniform manner, fast enough to sweep particles away from the direct compounding area (DCA). Critical sites in the DCA are exposed to that unidirectional HEPA-filtered air, also known as first air.

  • Laminar airflow workbench (LAFW). A type of laminar airflow system (LAFS) that provides ISO Class 5 or better air with unidirectional HEPA-filtered airflow. Laminar airflow is a non-turbulent, non-mixing streamline flow of air in parallel layers. A LAFS used for Category 2 or Category 3 CSPs must sit in a cleanroom suite with an ISO Class 7 or better buffer room and an ISO Class 8 or better anteroom. A dynamic airflow smoke pattern test is done in it initially and at least every 6 months.
  • Biological safety cabinet (BSC). A ventilated cabinet in three classes: Class I, Class II and Class III. Class II is split into Types A1, A2, B1, B2 and C1. A Class II BSC has an open front, inward and downward unidirectional HEPA-filtered airflow, and HEPA-filtered exhaust. Class II and Class III BSCs provide ISO Class 5 air for sterile compounding. Class I BSCs are for nonsterile compounding only. BSCs are typically used for hazardous preparations, and a BSC used for hazardous drugs must exhaust to the outdoors.
  • Compounding aseptic isolator (CAI) and compounding aseptic containment isolator (CACI). Both are restricted-access barrier systems (RABS) that provide ISO Class 5 unidirectional air. A CAI is designed for sterile non-hazardous drugs and a CACI for sterile hazardous drugs. For Category 2 CSPs, either one must sit in a cleanroom suite with an ISO Class 7 or better buffer room and an ISO Class 8 or better anteroom.
  • Pharmaceutical isolator. For Category 2 CSPs it must be placed in an ISO Class 8 or better positive-pressure room.
  • Integrated vertical laminar flow zone (IVLFZ). A designated ISO Class 5 area that serves as the PEC within an ISO Class 7 or cleaner buffer room.

Working in the hood: every item is wiped with sterile 70% isopropyl alcohol (IPA) and sterile low-lint wipers just before it goes into the PEC, and it is allowed to dry before use. When compounding takes 30 minutes or less, sterile 70% IPA is applied to the PEC work surface at least every 30 minutes.

Hand hygiene and garbing order

Before entering a compounding area, staff must:

  • Remove outer garments such as coats, hats, jackets and sweaters.
  • Remove all cosmetics, which shed flakes and particles.
  • Remove hand, wrist and other exposed jewelry, and cover any that cannot be removed.
  • Not wear earbuds or headphones, nail polish, artificial nails or extenders.
  • Wipe eyeglasses, if worn.
  • Leave food, mints, gum and drinks outside the anteroom, buffer room and SCA.

Anyone with a rash, a recent tattoo, oozing sores, conjunctivitis or an active respiratory infection must report it to the designated person, because these raise the risk of contaminating the CSP.

Hand hygiene

  • Clean under the nails with a disposable nail cleaner under warm running water.
  • Wash hands and forearms up to the elbows with soap and water for at least 30 seconds.
  • Brushes and hand dryers must not be used, and disposable soap containers must not be refilled or topped off.
  • Sanitize hands with alcohol-based hand rub before putting on sterile gloves.

If hand washing happens outside a classified area, alcohol-based hand rub must be used before garbing.

Minimum garb for Category 1 and Category 2

  • Low-lint gown or coverall with snug sleeves at the wrists and an enclosed neck
  • Low-lint shoe covers
  • Low-lint head cover over the hair and ears, plus a facial hair cover if needed
  • Low-lint face mask
  • Sterile powder-free gloves

The garbing order

USP 797 does not specify the order and location of garbing. Each facility sets the order in its SOPs, and garb must be put on and taken off in an order that reduces the risk of contamination. USP's FAQ gives this example for an SCA with a sink:

  1. Put on head, face and shoe covers, in the order the facility sets.
  2. Wash hands, then put on the gown.
  3. Apply alcohol-based hand rub to all surfaces of the hands and fingers, let it dry, then put on sterile gloves.

Whatever the order, these rules hold:

  • Sterile gloves are put on in a classified room or the SCA.
  • Skin must not be exposed inside the ISO Class 5 PEC, so gloves are never put on or taken off inside it.
  • Sterile 70% IPA is applied to gloves immediately before compounding and regularly throughout.
  • For nonhazardous Category 1 and 2 work, a gown can be reused by the same person within the same shift if it is kept in a classified area or within or next to the SCA. Other garb cannot be reused after leaving the compounding area.
  • In a Category 3 buffer room, no skin may be exposed (face and neck covered) and all low-lint outer garb must be sterile.

Personnel competency: gloved fingertip testing and media fill

Staff who compound, or who directly oversee compounders, must train and pass these evaluations before working independently:

EvaluationInitiallyCategory 1 and 2 compoundersCategory 3 compounders
Core training: hand hygiene, garbing, cleaning and disinfection, calculations, aseptic technique and moreBefore compoundingAt least every 12 monthsAt least every 12 months
Garbing competency: visual observation plus gloved fingertip and thumb sampling of both hands3 separate passes in a rowAt least every 6 monthsAt least every 3 months
Aseptic manipulation competency: visual observation, media fill, gloved fingertip and thumb sampling, surface sampling1 passAt least every 6 monthsAt least every 3 months
  • Initial garbing: 3 separate passes, each after a complete hand hygiene and garbing procedure. The 3 passes must come in a row.
  • Gloved fingertip and thumb sampling after garbing is taken from both hands before sterile 70% IPA is applied to the gloves. The action level is more than 0 colony-forming units (cfu), counted across both hands.
  • Media fill: the compounder simulates the most difficult and challenging procedures they perform, with soybean casein digest media in place of every component. Samples incubate for 7 days at each of two temperatures.
  • Gloved fingertip and thumb sampling after the media fill is taken from both hands immediately afterwards, inside the ISO Class 5 PEC. The action level is more than 3 cfu.
  • Failure: a failed media fill, fingertip sample or surface sample counts as a failure of the whole aseptic manipulation evaluation.
  • Supervisors who do not compound complete garbing and aseptic manipulation evaluations at least every 12 months.
  • Staff who only make immediate-use CSPsdo not need media fills. The facility's SOPs decide how their competency is checked.
  • Staff who only restock or clean outside the PEC are trained, show competency, and follow the hygiene and garbing rules.

Practice now: the Patient Safety quiz draws 25 timed questions from the full patient safety question bank, which includes sterile compounding, nonsterile compounding and hand hygiene questions.

USP 795: nonsterile compounding basics

USP 795 provides standards for compounding quality nonsterile preparations. It defines nonsterile compounding as combining, admixing, diluting, pooling, reconstituting other than as provided in the manufacturer's labeling, or otherwise altering a drug product or bulk drug substance to create a nonsterile preparation. The revised USP 795 was also published on November 1, 2022 and became official on November 1, 2023.

Outside USP 795:

  • Breaking or cutting a tablet into smaller portions.
  • Reconstituting a manufactured product as its approved labeling directs.
  • Administration: preparing a single dose for a single patient when administration will begin within 4 hours, including crushing a tablet or opening a capsule into food or liquid.

A compounding area must be designated for nonsterile compounding, and other activities must not happen there while compounding is going on. Compounders and their supervisors train initially and at least every 12 months. The revision dropped the old simple, moderate and complex categories of compounding.

USP 795 beyond-use dates

USP 795 sets default BUDs by water activity (aw), which USP introduced to assess a preparation's susceptibility to microbial contamination and to degradation by hydrolysis. Compounders do not have to measure aw. It is a guide for assigning BUDs. These defaults apply when there is no USP-NF compounded preparation monograph or preparation-specific stability data:

Dosage formWater activityBUDStorage
Nonpreserved aqueous dosage forms0.60 or higher14 daysRefrigerator
Preserved aqueous dosage forms0.60 or higher35 daysControlled room temperature or refrigerator
Oral liquids (nonaqueous)Below 0.6090 daysControlled room temperature or refrigerator
Other nonaqueous dosage formsBelow 0.60180 daysControlled room temperature or refrigerator

With suitable stability data a BUD can be extended past these defaults, up to a maximum of 180 days.

Sterile or nonsterile?

USP's FAQ answers which preparations must be made sterile. Ophthalmic products and compounded aqueous inhalation solutions and suspensions must be sterile. Otic preparations do not need to be sterile unless the patient has a perforated eardrum. Mouth, rectal and sinus irrigations and nasal sprays do not need to be sterile.

How USP 797 relates to USP 800

USP 800 governs handling hazardous drugs. When a sterile preparation contains a hazardous drug, the compounder must meet both USP 797 and USP 800, and nonsterile hazardous drug compounding must meet USP 800 as well as USP 795. USP 800 became official on December 1, 2019, and USP made it applicable from November 1, 2023 to entities required to follow USP 795 and USP 797. One difference shows up in the cleanroom: an anteroom that opens onto a negative-pressure buffer room must be at least ISO Class 7. The NIOSH list, hazardous drug PPE and containment are covered in our hazardous drugs guide.

Common exam traps

  • Using the old risk levels. Low, medium and high risk belong to the previous chapter. The revised chapter uses Category 1, 2 and 3, so old BUDs such as 48 hours at room temperature for a low-risk CSP are out of date.
  • Saying USP enforces USP 797. USP has no role in enforcement. State boards oversee state-licensed pharmacies, and FDA primarily oversees 503B outsourcing facilities.
  • Using a 1-hour immediate-use window. The revised chapter allows administration to begin within 4 hours of the start of preparation, with no more than 3 different sterile products.
  • Reading ISO numbers backwards. ISO Class 5 is the cleanest of the three. The PEC is ISO 5, the buffer room ISO 7, the anteroom ISO 8.
  • Putting on gloves inside the hood. Sterile gloves go on in the classified room or SCA. Skin must never be exposed inside the ISO Class 5 PEC.
  • Mixing up the fingertip action levels. More than 0 cfu after garbing, more than 3 cfu after a media fill.
  • Refrigerating to extend a BUD. BUDs are not additive. A room temperature BUD stays a room temperature BUD.
  • Confusing in-use limits. A single-dose vial punctured in ISO Class 5 air lasts up to 12 hours, an opened ampule is not stored at all, and a multiple-dose container lasts 28 days after first puncture unless the labeling says otherwise.
  • Picking a Class I BSC for sterile work. Class I is for nonsterile compounding only. Class II and III provide ISO Class 5 air.
  • Swapping the USP 795 aqueous BUDs. Preserved aqueous forms get 35 days. Nonpreserved aqueous forms get 14 days, refrigerated.

Frequently asked questions

What is USP 797?

USP 797 is the United States Pharmacopeia's General Chapter <797>, the standard for compounding sterile preparations (CSPs) such as injections, IV infusions and injections into the eye or spine. It sets requirements for compounding personnel and their training, facilities, environmental monitoring, and the storage and testing of finished preparations. It applies to everyone who prepares CSPs, pharmacy technicians included.

When did the revised USP 797 become official?

USP published the revised chapter on November 1, 2022, and it became official on November 1, 2023. USP's Compounding Expert Committee voted to extend the official date to allow more flexibility for adoption. State boards of pharmacy may set a different official date.

What is sterile compounding?

USP defines sterile compounding as combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile medication. Preparing a single dose for one patient exactly as the approved labeling directs is not compounding when the labeling gives the diluent, resulting strength, container closure system and storage time. Withdrawing a dose or spiking an IV bag with no further manipulation is administration, not compounding.

What is non-sterile compounding?

USP 795 defines nonsterile compounding as combining, admixing, diluting, pooling, reconstituting other than as provided in the manufacturer's labeling, or otherwise altering a drug product or bulk drug substance to create a nonsterile preparation. Splitting a tablet, reconstituting a product as its labeling directs, and crushing a tablet into food for a single dose that will be given within 4 hours are outside the chapter.

What are the USP 797 beyond-use dates?

Category 1 CSPs get 12 hours or less at controlled room temperature or 24 hours or less refrigerated. Category 2 limits depend on how the CSP is made and stored: an aseptically prepared CSP made only from sterile components with no sterility testing gets 4 days at room temperature, 10 days refrigerated or 45 days frozen. Category 3 CSPs can go up to 180 days. These are maximums, and a shorter BUD must be assigned when stability or sterility is shorter.

Who enforces USP 797?

USP does not. USP says compliance is the responsibility of the applicable regulatory jurisdiction and that it has no role in enforcement. State boards of pharmacy have primary responsibility for day-to-day oversight of state-licensed pharmacies, and FDA also conducts surveillance and for-cause inspections of them. Outsourcing facilities registered under section 503B are primarily overseen by FDA and must meet current good manufacturing practice (CGMP) requirements.

What is an immediate-use CSP?

An immediate-use CSP is made for direct and immediate administration and is exempt from the Category 1, 2 and 3 requirements when every condition is met. The main ones: aseptic technique under written procedures by trained staff, no more than 3 different sterile products, leftover single-dose product discarded, and administration starting within 4 hours of the start of preparation. Unless the person who prepared it gives it or watches it given, it must be labeled with the ingredients and amounts, the preparer's name or initials, and the 4-hour window.

What ISO class is a laminar flow hood?

A laminar airflow workbench (LAFW) is a primary engineering control that provides ISO Class 5 or better air with unidirectional HEPA-filtered airflow. When it is used for Category 2 or Category 3 CSPs it must sit in a cleanroom suite with an ISO Class 7 or better buffer room and an ISO Class 8 or better anteroom. If only Category 1 CSPs are made, it may sit in an unclassified segregated compounding area.

What is the difference between USP 795, 797 and 800?

USP 795 covers compounding nonsterile preparations, such as oral liquids. USP 797 covers compounding sterile preparations, such as injections and IV infusions. USP 800 covers handling hazardous drugs. When a preparation contains a hazardous drug, the compounder must also meet USP 800.

Keep studying

Hand hygiene, PPE and cleaning questions sit in the Patient Safety domain. Drill them with the Patient Safety quiz and use the Patient Safety & Quality Assurance domain guide to see the rest of the domain. For BUD and storage questions, work through the drug storage and expiration practice questions. Hazardous drug handling under USP 800 is in the hazardous drugs guide, and if you plan to specialize in sterile compounding, read about the CSPT exam.

PTCB Quiz Prepis an independent study resource, not affiliated with the Pharmacy Technician Certification Board or the United States Pharmacopeia. This page is exam reference framing, not compliance advice. Follow your state board of pharmacy's rules and the current USP chapters.